REFERENCES
1. Espinoza JL, Kotecha R, Nakao S. Microbe-Induced Inflammatory Signals Triggering Acquired Bone Marrow Failure Syndromes. Front Immunol. 2017;8:186. doi: 10.3389/fimmu.2017.00186.
2. Li JP, Zheng CL, Han ZC. Abnormal immunity and stem/progenitor cells in acquired aplastic anemia. Crit Rev Oncol Hematol.2010;75(2):79-93. doi: 10.1016/j.critrevonc.2009.12.001.
3. Fujisaki J, Wu J, Carlson AL, et al. In vivo imaging of Treg cells providing immune privilege to the haematopoietic stem-cell niche.Nature. 2011;474(7350):216-219.  doi: 10.1038/nature10160.
4. Panduro M, Benoist C, Mathis D. Tissue Tregs. Annu Rev Immunol. 2016;34:609-633. doi: 10.1146/annurev-immunol-032712-095948.
5. Lee HJ, Li CW, Hammerstad SS, Stefan M, Tomer Y. Immunogenetics of autoimmune thyroid diseases: A comprehensive review. J Autoimmun.2015;64:82-90. doi: 10.1016/j.jaut.2015.07.009.
6. Speiser JJ, Mondo D, Mehta V, Marcial SA, Kini A, Hutchens KA. Regulatory T-cells in alopecia areata. J Cutan Pathol.2019;46(9):653-658. doi: 10.1111/cup.13479.
7. Barone A, Lucarelli A, Onofrillo D, et al. Marrow Failure Study Group of the Pediatric Haemato-Oncology Italian Association. Diagnosis and management of acquired aplastic anemia in childhood. Guidelines from the Marrow Failure Study Group of the Pediatric Haemato-Oncology Italian Association (AIEOP). Blood Cells Mol Dis. 2015;55(1):40-47. doi: 10.1016/j.bcmd.2015.03.007.
8. Hasle H, Niemeyer CM, Chessells JM, et al. A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases. Leukemia. 2003;17(2):277-282. doi: 10.1038/sj.leu.2402765.
9. Lo Celso C, Fleming HE, Wu JW, et al. Live-animal tracking of individual haematopoietic stem/progenitor cells in their niche.Nature. 2009;457(7225):92-96. doi: 10.1038/nature07434.
10. Hall BM, Hall RM, Tran GT, et al. Interleukin-5 (IL-5) Therapy Prevents Allograft Rejection by Promoting CD4+CD25Ts2 Regulatory Cells That Are Antigen-Specific and Express IL-5 Receptor. Front Immunol.2021;12:714838.  doi: 10.3389/fimmu.2021.714838.
11. Sakai R, Yamagami S, Inoki T, Tsuru T, Kawashima H. Th1/Th2-balance in anterior chamber-associated immune deviation by alloantigen.Graefes Arch Clin Exp Ophthalmol. 2002;240(2):154-159. doi: 10.1007/s00417-001-0422-2.
12. Hirata Y, Furuhashi K, Ishii H, et al. CD150high Bone Marrow Tregs Maintain Hematopoietic Stem Cell Quiescence and Immune Privilege via Adenosine. Cell Stem Cell. 2018;22(3):445-453.e5. doi: 10.1016/j.stem.2018.01.017.
13. Ding L, Morrison SJ. Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches. Nature.2013;495(7440):231-235. doi: 10.1016/j.stem.2018.01.017.
14. Hirata Y, Kakiuchi M, Robson SC, Fujisaki J. CD150high CD4 T cells and CD150high regulatory T cells regulate hematopoietic stem cell quiescence via CD73. Haematologica.2019;104(6):1136-1142. doi: 10.3324/haematol.2018.198283.
15. Shi J, Ge M, Lu S, et al. Intrinsic impairment of CD4+CD25+ regulatory T cells in acquired aplastic anemia. Blood. 2012;120(8):1624-1632. doi: 10.1182/blood-2011-11-390708.
16. Li J, Lu S, Yang S, et al. Impaired immunomodulatory ability of bone marrow mesenchymal stem cells on CD4+ T cells in aplastic anemia. Results Immunol. 2012;2:142-147.  doi: 10.1016/j.rinim.2012.07.002.
17. Dutta A, De R, Dolai TK, Mitra PK, Halder A. Changes in Different Cytokines (IL-2, TNF-α, and IFN-γ) Profile in Acquired Aplastic Anemia Patients: A Study From Eastern India. J Pediatr Hematol Oncol.2020;42(3):185-192. doi: 10.1097/MPH.0000000000001737.
18. Coursey TG, Chen PW, Niederkorn JY. IL-17-dependent, IFN-gamma-independent tumor rejection is mediated by cytotoxic T lymphocytes and occurs at extraocular sites, but is excluded from the eye. J Immunol. 2011;187(8):4219-28. doi: 10.4049/jimmunol.1100826.
19. Kordasti S, Costantini B, Seidl T, et al. Deep phenotyping of Tregs identifies an immune signature for idiopathic aplastic anemia and predicts response to treatment. Blood. 2016;128(9):1193-1205. doi: 10.1182/blood-2016-03-703702.
20. Niederkorn JY, Chen PW, Mellon J, Stevens C, Mayhew E. Allergic conjunctivitis exacerbates corneal allograft rejection by activating Th1 and Th2 alloimmune responses. J Immunol. 2010;184(11):6076-6083. doi: 10.4049/jimmunol.0902300.
21. Speiser JJ, Mondo D, Mehta V, Marcial SA, Kini A, Hutchens KA. Regulatory T-cells in alopecia areata. J Cutan Pathol.2019;46(9):653-658. doi: 10.1111/cup.13479.
22. Takayama N, Murison A, Takayanagi SI, et al. The Transition from Quiescent to Activated States in Human Hematopoietic Stem Cells Is Governed by Dynamic 3D Genome Reorganization. Cell Stem Cell.2021;28(3):488-501.e10. doi: 10.1016/j.stem.2020.11.001.
23. Zeng Y, Katsanis E. The complex pathophysiology of acquired aplastic anaemia. Clin Exp Immunol. 2015;180(3):361-370. doi: 10.1111/cei.12605.
24. Jiang S, Wang Y, Shi W, et al. The benefit of ATG in immunosuppressive therapy of children with moderate aplastic anemia.Pediatr Hematol Oncol. 2009;26(5):313-320. doi: 10.1080/08880010902771549.
25. Howard SC, Naidu PE, Hu XJ, et al. Natural history of moderate aplastic anemia in children. Pediatr Blood Cancer.2004;43(5):545-551. doi: 10.1002/pbc.20131.